Literature DB >> 30072282

Executive summary: Consensus document of the diagnosis, management and prevention of infection with the hepatitis E virus: Study Group for Viral Hepatitis (GEHEP) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC).

Antonio Rivero-Juárez1, Antonio Aguilera2, Ana Avellón3, Miguel García-Deltoro4, Federico García5, Christian Gortazar6, Rafael Granados7, Juan Macías8, Nicolás Merchante8, José Antonio Oteo9, María Teresa Pérez-Gracia10, Juan Antonio Pineda8, Antonio Rivero11, David Rodriguez-Lazaro12, Francisco Téllez13, Luis E Morano-Amado14.   

Abstract

Hepatitis E virus (HEV) infection is one of the main causes of acute hepatitis in both developed and developing countries. This infectious disease has a high prevalence and incidence in Europe. HEV infection has a greater clinical impact in vulnerable populations, such as immunosuppressed patients, pregnant women and patients with underlying liver disease. Therefore, the Study Group for Viral Hepatitis (Grupo de Estudio de Hepatitis Víricas, GEHEP) of the Spanish Society of Infectious Diseases and Clinical Microbiology (Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica, SEIMC) believed it very important to prepare a consensus document to help in decision-making regarding diagnosis, clinical and therapeutic management, and prevention of HEV infection.
Copyright © 2018 Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. All rights reserved.

Entities:  

Keywords:  Acute hepatitis; Alteraciones neurológicas; Chronic hepatitis; Embarazo; Hepatitis E; Hepatitis aguda; Hepatitis crónica; Interferón pegilado; Neurological disorders; Pegylated interferon; Pregnancy; Prevención; Prevention; Ribavirin; Ribavirina; Transplantation; Trasplante; Zoonoses; Zoonosis

Mesh：

Year:  2018        PMID： 30072282     DOI： 10.1016/j.eimc.2018.06.014

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin (Engl Ed)        ISSN： 2529-993X


  8 in total

1.  Donor-Derived Genotype 4 Hepatitis E Virus Infection, Hong Kong, China, 2018.

Authors:  Siddharth Sridhar; Vincent C C Cheng; Shuk-Ching Wong; Cyril C Y Yip; Shusheng Wu; Anthony W I Lo; Kit-Hang Leung; Winger W N Mak; Jianpiao Cai; Xin Li; Jasper F W Chan; Susanna K P Lau; Patrick C Y Woo; Wai-Ming Lai; Tze-Hoi Kwan; Timmy W K Au; Chung-Mau Lo; Sally C Y Wong; Kwok-Yung Yuen
Journal:  Emerg Infect Dis       Date:  2019-03       Impact factor: 6.883

2.  Hepatitis E Infection in HIV-Infected Patients.

Authors:  Antonio Rivero-Juarez; Pedro Lopez-Lopez; Mario Frias; Antonio Rivero
Journal:  Front Microbiol       Date:  2019-06-26       Impact factor: 5.640

3.  Standardising surveillance of hepatitis E virus infection in the EU/EEA: A review of national practices and suggestions for the way forward.

Authors:  Cornelia Adlhoch; Zdenka Manďáková; Steen Ethelberg; Jevgenia Epštein; Ruska Rimhanen-Finne; Julie Figoni; Sally A Baylis; Mirko Faber; Kassiani Mellou; Niamh Murphy; Joanne O'Gorman; Maria Elena Tosti; Anna Rita Ciccaglione; Agnetha Hofhuis; Hans Zaaijer; Heidi Lange; Rita de Sousa; Ana Avellón; Lena Sundqvist; Bengü Said; Samreen Ijaz
Journal:  J Clin Virol       Date:  2019-09-19       Impact factor: 3.168

4.  Hepatitis E 3ra Genotype Infection in People Living With HIV in Spain.

Authors:  Antonio Rivero-Juarez; Mario Frias; Pedro Lopez-Lopez; Juan Berenguer; Federico García; Juan Macias; Begoña Alcaraz; Angeles Castro-Iglesias; Javier Caballero-Gomez; Antonio Rivero
Journal:  Front Microbiol       Date:  2020-09-11       Impact factor: 5.640

Review 5.  Towards the Improved Accuracy of Hepatitis E Diagnosis in Vulnerable and Target Groups: A Global Perspective on the Current State of Knowledge and the Implications for Practice.

Authors:  Jasminka Talapko; Tomislav Meštrović; Emina Pustijanac; Ivana Škrlec
Journal:  Healthcare (Basel)       Date:  2021-01-29

6.  Mutations in the Progesterone Receptor (PROGINS) May Reduce the Symptoms of Acute Hepatitis E and Protect Against Infection.

Authors:  Pedro López-López; Antonio Rivero-Juarez; Mario Frias; Isabel Machuca; Javier Caballero-Gómez; Israel Olivas; Angela Camacho; María de Los Angeles Risalde; Ignacio García-Bocanegra; Antonio Rivero
Journal:  Front Microbiol       Date:  2019-11-07       Impact factor: 5.640

7.  Ribavirin as a First Treatment Approach for Hepatitis E Virus Infection in Transplant Recipient Patients.

Authors:  Antonio Rivero-Juarez; Nicolau Vallejo; Pedro Lopez-Lopez; Ana Isabel Díaz-Mareque; Mario Frias; Aldara Vallejo; Javier Caballero-Gómez; María Rodríguez-Velasco; Esther Molina; Antonio Aguilera
Journal:  Microorganisms       Date:  2019-12-26

8.  Limited Value of Single Sampling for IgM Antibody Determination as a Diagnostic Approach for Acute Hepatitis E Virus Infection.

Authors:  Antonio Rivero-Juarez; Pedro Lopez-Lopez; Juan Antonio Pineda; Juan Carlos Alados; Ana Fuentes-López; Encarnación Ramirez-Arellano; Carolina Freyre; Ana Belén Perez; Mario Frias; Antonio Rivero
Journal:  Microbiol Spectr       Date:  2021-07-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.